EZVIZ Unveils HP7 Pro, Industry’s First 4K Palm Vein Video Doorphone, Making Home Entry Easier and Safer
EZVIZ pioneers next-level entry technology with the groundbreaking HP7 Pro 4K Palm Vein Video Doorphone. This innovative device redefines the internet-connected intercom by integrating secure unlocking with exceptional visual clarity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715927093/en/
The HP7 Pro marks an industry first, combining stunning 4K Ultra HD resolution with advanced palm vein scanning technology. This transforms it beyond communication – it becomes a secure smart lock and a vigilant smart camera, creating a personalized gateway for modern homes.
Solving Real Access Challenges:
"Traditional keys and passwords often fall short," says Binghong Wang, EZVIZ Product Research Lead. "The HP7 Pro’s AI-powered on-device recognition identifies who is at the door. Palm vein patterns are internal and nearly impossible to replicate, offering strong protection against spoofing. Simply wave your hand or glance at the camera – access is granted in under a second. Coupled with 4K clarity, families see every visitor with unparalleled detail, day or night."
Next-Gen Clarity & Security:
Beyond access control, the HP7 Pro excels in monitoring capabilities. Its 4K lens with large aperture captures sharp details. WDR handles challenging light, distortion correction delivers true-to-life images, and ColorFULL night vision provides full-color video in low light, enhancing nighttime security and awareness.
Unrivaled Convenience:
Offering ultimate flexibility, the HP7 Pro supports multiple unlock methods: palm vein scanning, facial recognition, password input, RFID badge, app access for family, touch on indoor screen, and QR codes for guests. Powered by an on-device AI chip and dual-core CPU, it processes data locally for speed, accuracy, and privacy, instantly alerting on unknown entries.
Smart Home Hub Integration:
More than just a doorbell, the HP7 Pro's 8-inch indoor touch screen becomes a central command hub. Manage EZVIZ devices, check history logs, or answer the door remotely via the app – all with simple taps. Easy 2-wire installation and a sleek design seamlessly replace outdated intercoms.
Honored with the 2025 MUSE Design Award, the HP7 Pro exemplifies EZVIZ's commitment to user-centered innovation. "We aimed to solve real problems facing home entry," states Wang. "Smart design that listens makes moments like coming home easier, safer, and more connected."
The EZVIZ HP7 Pro sets a new standard, merging robust security, exceptional visual intelligence, and convenient smart home control into one elegant solution.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250715927093/en/
Contacts
Hazel Han, hanxiao16@ezviz.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform16.12.2025 02:00:00 CET | Press Release
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stability studies supported Shine-On’s IND submission. The IND was cleared by the U.S. FDA in Q1 2025. Furthermore, Esco Aster is providing technical services for exploratory exosome loading feasibility studies per Shine-On’s instruction. Shine-On Biomedical is an emerging innovator in exosome-based drug delivery. ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G targeted exosome platfo
Civil Air Patrol Expands Fleet With 15 New Cessna Aircraft to Support Lifesaving and Community Missions15.12.2025 17:00:00 CET | Press Release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, announced today that Civil Air Patrol (CAP), the world’s largest operator of Cessna aircraft, is strengthening its national mission capabilities with an order for 15 additional piston-engine aircraft, including seven Cessna Skyhawk 172 and eight Cessna Skylane 182 models scheduled for delivery throughout 2026. The order follows recent deliveries of an additional two Cessna Skylane and one Cessna Turbo Stationair HD aircraft, expanding CAP’s fleet to more than 500 Cessna aircraft nationwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215613573/en/ Delivery of an additional two Cessna Skylane and one Cessna Turbo Stationair HD aircraft joins CAP’s fleet of more than 500 Cessna aircraft nationwide. Cessna aircraft are designed and produced by Textron Aviation. “Civil Air Patrol’s missions demand aircraft that are reliable, versatile and ready to perform in critic
Winston & Strawn and Taylor Wessing UK to Combine, Creating a Premier Transatlantic Law Firm15.12.2025 16:52:00 CET | Press Release
Winston & Strawn and Taylor Wessing’s UK-led business announced today their intention to combine, creating a premier transatlantic law firm that would operate under a new shared name, Winston Taylor. The combination responds to increasing client demand for seamlessly integrated US–UK–EU counsel for the businesses, people, and markets driving capital and innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215914957/en/ The combination once final will unite two international firms with more than 400 years of combined history, complementary strengths, and a common vision to meet clients’ evolving global needs. The combined firm will include more than 1,400 lawyers, establishing one of the largest transatlantic firms whose footprint is primarily in the United States, the United Kingdom, and Europe, and also in Latin America and the Middle East. Leveraging significant strength and scale in major litigation, critical tra
Despite Barriers, Financial Institutions are Clear About AI's Greatest Impact15.12.2025 16:32:00 CET | Press Release
HTEC, a global AI-first provider of software and hardware design and engineering services, today released The State of AI in Financial Services & Insurance 2025, a first industry subset of its global research report in AI. This publication offers one of the clearest views to date into how financial institutions are adopting and scaling artificial intelligence. This industry-focused report analyzes insights from 250 C-suite leaders within financial services and insurance, drawn from HTEC’s broader global study of 1,529 C-suite executives—including CIOs, CTOs, CDOs, CPOs, CFOs, COOs, CEOs and CSOs—across Saudi Arabia, the UAE, the United Kingdom, the United States, Germany and Spain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215790717/en/ Executive Summary: The State of AI in Financial Services and Insurance 2025 The findings confirm a decisive shift in the industry: not a single respondent said AI is not a priority. L
Align Partners Sends Second Public Shareholder Letter to Coway, Urging Announcement of Revised Value-up Plan by January 30, 202615.12.2025 15:54:00 CET | Press Release
Align Partners Capital Management Inc. (“Align Partners”), a shareholder of Coway Co., Ltd. (“Coway”) since 2023 holding more than 4% of the Company’s outstanding shares through funds it manages or advises, announced that it has sent a second public shareholder letter to Coway’s Board of Directors. The letter calls for measures to address the company’s chronic undervaluation and enhance shareholder value. Align Partners has requested that Coway announce a revised corporate Value-up Plan reflecting these proposals by January 30, 2026. In the letter, Align Partners assessed Coway’s February 2025 plan as insufficient to address Coway’s persistent undervaluation and urged the Board to incorporate seven measures: (1) clear mid-to-long-term valuation and ROE targets with execution plans; (2) clarified and strengthened target capital structure policy; (3) updated shareholder return policy reflecting both the target capital structure policy and new dividend income tax separation regime; (4) en
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom